Downtrend on the daily chart: below its 50- and 200-day averages · 50-day below the 200-day · SuperTrend down since Aug 14 · below the Ichimoku cloud · RSI 43 · MACD below its signal
None of the 29 investors followed here reported a position in GTHP in their latest filing.
From each investor's quarterly 13F filing with the SEC: positions at the quarter's end, reported up to 45 days later. All investors
No member of Congress has disclosed a GTHP trade since 2025.
From House and Senate STOCK Act reports. Members disclose trades, not holdings, as value ranges up to 45 days later, so amounts are estimates and “last move” is a hint at who still holds it, not a position. All recent congress trades
No insider transactions reported for GTHP.
| Year | Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec | Year |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026 | -7.8 | -25.7 | -37.8 | 8.7 | -8.4 | 4.8 | 25.0 | -25.0 | 10.2 | -23.4 | −64.8% | ||
| 2025 | -13.3 | -13.8 | -10.7 | 5.0 | 33.3 | 78.6 | -11.2 | 26.1 | -14.3 | 12.5 | -7.4 | 116.0 | +260.0% |
| 2024 | -9.1 | 2.9 | -19.4 | -6.0 | -8.3 | 20.0 | 0.0 | 15.0 | 26.8 | 14.3 | -5.0 | -21.1 | −2.6% |
| 2023 | 15.3 | -16.2 | -20.7 | 4.3 | -20.8 | 18.4 | -35.6 | 3.4 | 10.0 | -9.1 | -10.0 | 14.1 | −48.7% |
| 2022 | 3.4 | -12.5 | 23.8 | -4.6 | -17.7 | -3.9 | 6.1 | -5.8 | 4.1 | -41.2 | 16.3 | -14.0 | −48.3% |
| 2021 | 64.6 | 5.4 | -5.2 | -25.1 | 6.4 | -6.3 | -6.8 | 1.8 | 1.8 | 18.4 | -14.1 | +20.8% |
No analyst coverage for this instrument.
Guided Therapeutics, Inc., a medical technology company, researches, develops, tests, manufactures, sells, and distributes medical devices in the United States and internationally. It offers LuViva, an advanced cervical scan non-invasive cervical cancer detection device that provides less invasive and painless alternative to conventional tests for identifying, screening, and detecting cervical cancers and precancers. The company was formerly known as SpectRx, Inc. and changed its name to Guided Therapeutics, Inc. in February 2008. Guided Therapeutics, Inc. was incorporated in 1992 and is headquartered in Peachtree Corners, Georgia.